MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
3.220
-0.280
-8.00%
Pre Market: 3.630 +0.41 +12.73% 08:27 12/23 EST
OPEN
3.500
PREV CLOSE
3.500
HIGH
3.680
LOW
3.220
VOLUME
550
TURNOVER
0
52 WEEK HIGH
9.20
52 WEEK LOW
2.370
MARKET CAP
21.91M
P/E (TTM)
-0.4307
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PYPD last week (1216-1220)?
Weekly Report · 3h ago
PolyPid’s Strategic Advancements and Clinical Progress: A Buy Recommendation
TipRanks · 12/16 11:36
Weekly Report: what happened at PYPD last week (1209-1213)?
Weekly Report · 12/16 09:44
PolyPid Ltd. Announces Research Collaboration with ImmunoGenesis to Enhance Immunotherapy for Solid Tumors
Barchart · 12/11 16:18
PolyPid (PYPD) Gets a Buy from Craig-Hallum
TipRanks · 12/11 13:47
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
TipRanks · 12/11 12:28
PolyPid announces research, development collaboration with ImmunoGenesis
TipRanks · 12/11 12:16
POLYPID ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH IMMUNOGENESIS LEVERAGING PLEX TECHNOLOGY TO ENHANCE CANCER IMMUNOTHERAPY
Reuters · 12/11 12:00
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.